Marsh & Mclennan Companies (MRSH) Cash & Equivalents (2009 - 2026)

Marsh & Mclennan Companies (MRSH) has 18 years of Cash & Equivalents data on file, last reported at $11.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 1.42% year-over-year to $11.7 billion; the trailing twelve-month figure through Mar 2026 stood at $11.7 billion (up 1.42% YoY), and the FY2025 full-year result was $11.5 billion, up 1.75% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $11.7 billion, up from $11.5 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $12.0 billion in Q3 2025 and bottomed at $772.0 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $10.7 billion (2022), against an average of $6.8 billion.
• The widest annual swing landed in 2023, when Cash & Equivalents surged 1374.81%; it then plunged 85.71% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $10.7 billion in 2022, then slumped by 68.5% to $3.4 billion in 2023, then jumped by 235.8% to $11.3 billion in 2024, then gained by 1.75% to $11.5 billion in 2025, then gained by 2.36% to $11.7 billion in 2026.
• The last three Cash & Equivalents figures came in at $11.7 billion (Q1 2026), $11.5 billion (Q4 2025), and $12.0 billion (Q3 2025), per Business Quant data.

Peer Comparison